Immunocore Holdings plc (IMCR) Executive Compensation
Immunocore Holdings plc (IMCR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMCR
CIK: 1671927
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerChristopher Aylott
Audit LocationCambridge, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002336 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001671927-26-000026 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003501 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000902219-26-000298 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002034 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001671927-26-000022 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001671927-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001969518-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001508596-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001919343-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001969522-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001969520-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 Filing | 0001969932-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001140361-26-022984 | View SEC Doc Filr Page |
| 144 | 2026-05-22 | — | 144 Filing | 0001974494-26-000187 | View SEC Doc Filr Page |
| 144 | 2026-05-21 | — | 144 Filing | 0001974494-26-000185 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000902664-26-002542 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001897612-26-000499 | View SEC Doc Filr Page |
| S-8 | 2026-05-08 | — | S-8 | 0001140361-26-019737 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001140361-26-019205 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001671927-26-000009 | View SEC Doc Filr Page |
| ARS | 2026-04-16 | 2025-12-31 | ARS | 0001140361-26-015125 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-16 | 2026-05-27 | DEF 14A | 0001140361-26-015122 | View SEC Doc Filr Page |
| 144 | 2026-04-08 | — | 144 Filing | 0001974494-26-000149 | View SEC Doc Filr Page |
| 144 | 2026-03-11 | — | 144 Filing | 0001974494-26-000121 | View SEC Doc Filr Page |